Startups

Medtronic

Dublin, Ireland · Minneapolis, Minnesota, United States

Medtronic plc, public medical-device company (NYSE MDT). Legal headquarters Dublin, operational headquarters Minneapolis. Neuromodulation is a business in its Neuroscience portfolio, including Percept and BrainSense DBS. Geoff Martha is parent CEO; Kweli Thompson leads Neuroscience.

Founded 1949

Team

Geoff MarthaChairman and CEO

Kweli ThompsonEVP / President, Neuroscience

Investments

$20M2016-08-15	Medtronic	Marc Andreessen
$40M2014-05-15	Inspire Medical Systems	OrbiMed, Kleiner Perkins, U.S. Venture Partners, Aperture Venture Partners, Medtronic
$14M2012-05-11	Inspire Medical Systems	Kleiner Perkins, U.S. Venture Partners, Medtronic
$17M2009-06-08	Inspire Medical Systems	Kleiner Perkins, U.S. Venture Partners, Medtronic

team@apexlogos.ai11 hours ago
BCI research snapshot, reviewed 2026-10-06. Company identity: Medtronic. This is the pre-import evidence dossier; historical statements about database absence or review are archival. Unverified claims remain research leads, not validated facts. Part 1/1 # Medtronic Neuromodulation Accessed: 2026-10-06. Research report for human review; no database changes made. Direct image URLs are extracted source assets, not invented filenames. Funding ledger is verified events found, not a complete lifetime total. ## Entity classification and pasted claims **Operating business, not a separate publicly traded company.** Neuromodulation is within the Neuroscience Portfolio of parent [Medtronic plc](https://www.medtronic.com/), NYSE MDT. Dublin is parent legal headquarters and Minneapolis the operational headquarters; 1949 is parent founding year, not proven division incorporation. [Company facts](https://news.medtronic.com/company-facts), [Percept issuer announcement describing organization](https://news.medtronic.com/2024-01-08-FDA-approves-Medtronic-Percept-TM-RC-neurostimulator-with-exclusive-BrainSense-TM-technology). Geoff Martha is parent chairman/CEO, not CEO of a standalone Neuromodulation company. **Kweli Thompson** became EVP/president Neuroscience in June2026, confirmed in [FY2026 annual filing](https://www.sec.gov/Archives/edgar/data/1613103/000162828026058626/fy26ars82426.pdf); older regional pages naming Brett Wall are stale. Active product business and parent ticker pass; pasted leadership/entity interpretation needs correction. Percept PC and BrainSense are real. Current platform also includes rechargeable Percept RC and BrainSense adaptive DBS. BrainSense records local field potentials through implanted DBS leads; this is sensing-guided therapeutic DBS, not general-purpose consumer thought decoding. [Official product](https://www.medtronic.com/en-us/healthcare-professionals/products/neurological/deep-brain-stimulation/electrical-stimulation-systems/percept-rc-neurostimulator.html), [BrainSense](https://www.medtronic.com/me-en/healthcare-professionals/products/neurological/deep-brain-stimulation-systems/brainsense.html). ## Images and relevant leadership Parent logo direct asset: https://www.medtronic.com/content/dam/medtronic-com/mdt_logo_white.png — actual official HTML image. White logo requires appropriate background; not a division-specific identity. | Person | Role / currency | Profile and evidence | Direct pfp URL | |---|---|---|---| | Geoff Martha | Current parent chairman / CEO | [Official leadership](https://www.medtronic.com/en-ca/our-company/leadership.html) | Unavailable: official image links returned access errors; no verified standalone URL captured. | | Kweli Thompson | Current EVP/president Neuroscience; June2026 | [SEC annual report](https://www.sec.gov/Archives/edgar/data/1613103/000162828026058626/fy26ars82426.pdf); [team](https://www.medtronic.com/en-ca/our-company/leadership.html) | Unavailable: current team photo was linked but asset output failed. | | Amaza Reitmeier | VP/GM Brain Modulation within Neuromodulation, last confirmed January2024; current 2026 currency unverified | [Official Percept release](https://news.medtronic.com/2024-01-08-FDA-approves-Medtronic-Percept-TM-RC-neurostimulator-with-exclusive-BrainSense-TM-technology) | Unavailable from consulted primary announcement. | | Brett Wall | Former Neuroscience president, replaced June2026 | [SEC current leadership evidence](https://www.sec.gov/Archives/edgar/data/1613103/000162828026058626/fy26ars82426.pdf) | Unavailable; historical profile not selected. | Parent founders Earl Bakken and Palmer Hermundslie belong to Medtronic’s parent history, not a new Neuromodulation startup. Public team investigation covered current North American leadership and older regional pages; no authoritative complete division roster was exposed. ## Investments / public financing No standalone venture financing round or independent publicly listed security for this division was established. “Public MDT” is a parent listing identifier, not a funding amount. Parent debt issuance, acquisitions and corporate revenue should not be imported as investments into a Neuromodulation startup. This research does not attempt to restate the entire parent treasury financing history; use SEC parent filings for public financing review. ## Review / import decision Enrich `Medtronic` with a neuromodulation business/product relationship or create an explicitly typed division. Existing `GoldiMedtronic` is a parent duplicate candidate; `MedtronicDigitalSurgery`/`MedtronicDigitalTechnologies` are other businesses and cannot substitute for this unit. Current division-level leader and team photographs remain gaps. Avoid a separate “company” carrying parent founder date, public ticker and CEO without an explicit parent relation.